Distinguishing Score 0 From Score 1+ in HER2 Immunohistochemistry-Negative Breast Cancer-Reference-Cited by-同舟云学术

Distinguishing Score 0 From Score 1+ in HER2 Immunohistochemistry-Negative Breast Cancer

Published:2013-10-01 Issue:4 Volume:140 Page:561-566
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Lambein Kathleen¹²,Van Bockstal Mieke¹²,Vandemaele Lies²,Geenen Sofie²,Rottiers Isabelle²,Nuyts Ann²,Matthys Bart²,Praet Marleen¹²,Denys Hannelore³,Libbrecht Louis¹²

Affiliation:

1. Department of Pathology, Ghent University, Ghent, Belgium

2. Department of Pathology, Ghent University Hospital, Ghent, Belgium

3. Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/140/4/561/24995611/ajcpath140-0561.pdf

Reference21 articles.

1. The HER-2 receptor and breast cancer: ten years of targeted anti–HER-2 therapy and personalized medicine;Ross;Oncologist,2009

2. ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer;Pinhel;Breast Cancer Res,2012

3. Even low-level HER2 expression may be associated with worse outcome in node-positive breast cancer;Gilcrease;Am J Surg Pathol,2009

4. HER2 intermediate breast cancers;Jensen;Am J Surg Pathol,2009

5. In response to Jensen KC, et al;Gilcrease;Am J Surg Pathol,2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence for assisted HER2 immunohistochemistry evaluation of breast cancer: A systematic review and meta-analysis;Pathology - Research and Practice;2024-08

2. The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer;Cancers;2024-07-17

3. Consensus Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2)-Low Testing in Breast Cancer in Malaysia;Cancers;2024-06-25

4. Concordance between pathologists and between specimen types in detection of HER2-low breast carcinoma by immunohistochemistry;Annals of Diagnostic Pathology;2024-06

5. The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study;Breast Cancer Research and Treatment;2024-05-14